PAVM – pavmed inc. (US:NASDAQ)
Stock Stats
News
4/10
08:00 am
pavm
Medium
PAVmed (PAVM) had its price target lowered by Ascendiant Capital Markets from $510.00 to $65.00. They now have a "buy" rating on the stock.
4/9
08:18 am
pavm
Low
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/8
09:52 pm
pavm
Low
How The PAVmed (PAVM) Narrative Is Shifting After The Latest Analyst Reassessment [Yahoo! Finance]
4/4
01:04 am
pavm
Low
PAVmed (PAVM) was upgraded by Wall Street Zen from "sell" to "hold".
4/2
08:32 am
pavm
Medium
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio [Yahoo! Finance]
11/13/2025
08:00 am
PAVM
-8.8%
BEAT
8/14/2025
08:00 am
PAVM
-3.9%
BEAT
4/14
04:06 pm
pavm
Low
Form SCHEDULE 13G/A PAVmed Inc. Filed by: Tasso Partners, LLC
4/13
04:11 pm
pavm
Low
Form 4 PAVmed Inc. For: Apr 02 Filed by: Lee Victoria Tou-ho
4/13
04:08 pm
pavm
Low
Form 3 PAVmed Inc. For: Mar 24 Filed by: Lee Victoria Tou-ho
4/13
11:13 am
pavm
Low
Form SCHEDULE 13G PAVmed Inc. Filed by: Scopia Holdings LLC
4/9
08:57 pm
pavm
Low
Form SCHEDULE 13D PAVmed Inc. Filed by: Aklog Lishan
Show more
Top News Gainers
3/24 PAVmed to Hold Business Update Conference Call on April 9, 2020 19.1%
3/30 Form NT 10-K PAVmed Inc. For: Dec 31 14.5%
4/9 PAVmed Reports Preliminary Fourth Quarter 2019 Financial Results and Provides Business Update 14.2%
2/11 U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test 14.2%
4/21 PAVmed Receives FDA 510(k) Clearance for its CarpX™ Minimally Invasive Carpal Tunnel Device 11.5%
6/25 Form 8-K PAVmed Inc. For: Jun 25 10.6%
12/13 PAVmed Provides Update on CarpX™ Clinical Safety Study 9.4%
3/9 Form 8-K PAVmed Inc. For: Mar 09 8.9%
5/22 Form S-8 PAVmed Inc. 7.8%
3/2 PAVmed Subsidiary Lucid Diagnostics Partners with University of Pennsylvania to Evaluate EsoCheck™ in Eosinophilic Esophagitis (EoE) Patients 7.1%
Top News Decliners
1/13 PAVmed Receives Formal Notification of Nasdaq Continued Listing Compliance -15.5%
11/5 PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization -12.5%
11/7 Form D PAVmed Inc. -10.9%
3/3 PAVmed Inc (NASDAQ: PAVM) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -10.2%
2/27 PAVmed Inc (NASDAQ: PAVM) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $5.00 price target on the stock. -8.3%
4/18 PAVmed Inc (NASDAQ: PAVM) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $5.00 price target on the stock. -7.7%
5/21 PAVmed Reports First Quarter 2019 Financial Results and Provides Business Update -6.8%
6/24 PAVmed Subsidiary Lucid Diagnostics Receives FDA 510(k) Clearance for EsoCheck™ -6.1%
5/1 Form 8-K PAVmed Inc. For: Apr 30 -6.0%
5/8 Form 424B5 PAVmed Inc. -5.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3